The Synthesis of a Prodrug of Doxorubicin Designed to Provide Reduced Systemic Toxicity and Greater Target Efficacy
作者:Victor M. Garsky、Patricia K. Lumma、Dong-Mei Feng、Jenny Wai、Harri G. Ramjit、Mohinder K. Sardana、Allen Oliff、Raymond E. Jones、Deborah DeFeo-Jones、Roger M. Freidinger
DOI:10.1021/jm0101996
日期:2001.11.1
have been found to correlate well with the number of malignant prostate cells. The use of a prodrug which is cleaved by the enzyme PSA in the prostate should in principle produce high localized concentrations of the cytotoxic agent at the tumor site while limiting systemic exposure to the active drug. Cleavage maps following PSA treatment of human semenogelin were constructed. Systematic modification